Cystic Fibrosis and Personalized Medicine: A Brief History

February 7, 2020
Leo Robert
Leo Robert

These concise summaries outline key developments in the evolution of a promising genetics-based approach to cystic fibrosis treatment.

Personalized medicine, also known as precision medicine, continues to advance as a genetics-based approach to treating patients with cystic fibrosis (CF). In this approach, personalized interventions are applied for patients who have specific mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Scroll through the slides below to find concise summaries of key developments in the evolution of personalized, or precision, medicine for patients with CF.